Squalene: potential chemopreventive agent

Bibliography

• AMERICAN INSTITUTE FOR CANCER RESEARCH: Food, Nutrition and the Prevention of Cancer: A Global Perspective. AICR, Washington DC, USA (1997):1–663.
   Google Scholar
• ••This book is a comprehensive review of diet and cancer.
   Google Scholar
• CHEMOPREVENTION WORKING GROUP: Prevention of cancer in the next millennium: report of the chemoprevention working group to the American association for cancer research. Cancer Res. (1999) 59:4743–4758.
   PubMed Web of Science ®Google Scholar
• ••Report summarises the progress, problems and future of thechemoprevention field.
   Google Scholar
• KELLOFF GJ, CROWELL JA, STEELE VE et al.: Progress in cancer chemoprevention. Ann. NY Acad. ScL (1999) 889:193–203.
   PubMed Web of Science ®Google Scholar
• ••Detailed survey of chemoprevention agents, theirmechanisms and molecular targets.
   Google Scholar
• KENSLER TW: Chemoprevention by inducers of carcinogen detoxication enzymes. Environ. Health Perspect. (1997) 105 (Suppl. 4):965–970.
   Google Scholar
• SMITH TJ, YANG CS: Effects of food phytochemicals on xenobiotic metabolism and tumorigenesis. In: Food Phytochemicals for Cancer Prevention L Fruits and Vegeta-bles. Huang M-T, Osawa T, Ho C-T, Rosen R (Eds.), ACS Symposium, Washington DC, USA (1994):17–48.
   Google Scholar
• BARTSCH H, NAIR J, OWEN RW: Dietary polyunsatu-rated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis (1999) 20:2209–2218.
   PubMed Web of Science ®Google Scholar
• REDDY BS: Dietary fat and colon cancer: Animal model studies. Lipids (1992) 27:807–813.
   PubMed Web of Science ®Google Scholar
• WYNDER EL, TAIOLI E, FUJITA Y: Ecologic study of lung cancer risk factors in the US and Japan, with special reference to smoking and diet. Jpn. j Cancer Res. (1992) 83:418–423.
   PubMedGoogle Scholar
• GERBER M: Olive oil and cancer. In: Epidemiology of Diet and Cancer. Hill M, Giacosa A, Caygill C (Eds.), Ellis Horwood, London, UK (1994):263–275.
   Google Scholar
• LAVECCHIA C, NEGRI E: Fats in seasoning and the relationship to pancreatic cancer. Eur. J. Cancer Prey. (1997) 6:370–373.
   PubMed Web of Science ®Google Scholar
• LAVECCHIA C, NEGRI E, FRANCESCHI S, DECARLI A, GIACOSA A, LIPWORTH L: Olive oil, other dietary fats and the risk of breast cancer (Italy). Cancer Causes Control (1995) 6:545–555.
   PubMed Web of Science ®Google Scholar
• MARTIN-MORENO JM, WILLET WC, GORGOJO L et al.: Dietary fat, olive oil intake and breast cancer risk. Int. J. Cancer (1994) 58:774–780.
   PubMed Web of Science ®Google Scholar
• TRICHOPOULOU A, KATSOUYANNI K, STUVER S et al.: Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. J. Natl. Cancer Inst. (1995) 87:110–116.
   PubMed Web of Science ®Google Scholar
• LIU GCK, AHRENS EH, JR., SCHREIBMAN PH, CROUSE JR: Measurement of squalene in human tissues and plasma: validation and application. J. Lipid Res. (1976) 17:38–45.
   Google Scholar
• OWEN RW, MIER W, HULL WE, GIACOCA A, SPIEGEL-HALDER B, BARTSCH H: The identification of lignans as major components of the phenolic fraction of olive oil. J. Cancer Res. Clin. Oncol. (1999) 125 (Suppl.):531.
   Google Scholar
• OWEN RW, MIER W, GIACOSA A, SPIEGELHALDER B, BARTSCH H: The concentration and antioxidant potential of total phenols, simple phenols, secoiri-doids and lignans in olive oil. J. Cancer Res. an. Oncol (1999) 125:S31–S32.
   Google Scholar
• KELLY GS: Squalene and its potential clinical uses. Altern. Med. Rev. (1999) 4:29–36.
   PubMedGoogle Scholar
• HARRIS CC: Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res. (1991) 51 (Suppl.):5023s–5044s.
   Google Scholar
• FEIG DI, REID TM, LOEB LA: Reactive oxygen species in tumorigenesis. Cancer Res. (1994) 54 (Suppl.):1890s–1894s.
   Google Scholar
• MARNETT LJ, JI C: Modulation of oxidant formation in mouse skin in vivo by tumor-promoting phorbol esters. Cancer Res. (1994) 54 (Suppl.):1886s–1889s.
   Google Scholar
• GUENGERICH FP: Metabolism of chemical carcinogens. Carcinogenesis (2000) 21:345–351.
   PubMed Web of Science ®Google Scholar
• MARNETT Oxyradicals and DNA damage. Carcino-genesis (2000) 21:361–370.
   PubMed Web of Science ®Google Scholar
• BIRT DF, KRIS ES, CHOE M, PELLING JC: Dietary, energy and fat effects on tumor promotion. Cancer Res. (1992) 52 (Suppl.):2035s–2039s.
   Google Scholar
• YUSPA SH: Overview of carcinogenesis: past, present and future. Carcinogenesis (2000) 21:341–344.
   PubMed Web of Science ®Google Scholar
• YOKOTA J: Tumor progression and metastasis. Carcinogenesis (2000) 21:497–503.
   PubMed Web of Science ®Google Scholar
• PLUDA J: Tumor-associated angiogenesis: mechanisms, clinical implications and therapeutic strategies. Semin. Oncol. (1997) 24:203–221.
   PubMed Web of Science ®Google Scholar
• RAO CV, NEWMARK HL, REDDY BS: Chemopreventive effect of squalene on colon cancer. Carcinogenesis (1998) 19:287–290.
   PubMed Web of Science ®Google Scholar
• CHAN P, TOMLINSON B, LEE C-B, LEE Y-S: Effectivenessand safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hyper cholesterolemia. J. Clin. PharmacoL (1996) 36:422–427.
   PubMed Web of Science ®Google Scholar
• KRITCHEVSKY D, MOYER AW, TESAR WC, LOGAN JB, BROWN RA, RICHMOND G: Squalene feeding in experi-mental atherosclerosis. Circ. Res. (1954) 11:340–343.
   Web of Science ®Google Scholar
• STRANDBERG TE, TILVIS RS, MIETTINEN TA: Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment. J. Lipid Res. (1990) 31:1637–1643.
   PubMed Web of Science ®Google Scholar
• TILVIS RS, MIETTINEN TA: Dietary squalene increases tissue sterols and fecal bile acids in the rat. Lipids (1983) 18:32–36.
   PubMed Web of Science ®Google Scholar
• MIETTINEN TA, VANHANEN H: Serum concentration and metabolism of cholesterol during rap eseed oil and squalene feeding. Am. J. Clin. Nutr. (1994) 59:356–363.
   PubMed Web of Science ®Google Scholar
• GYLLING H, MIETTINEN TA: Postabsorptive metabolism of dietary squalene. Atherosclerosis (1994) 106:169–178.
   PubMed Web of Science ®Google Scholar
• SMITH TJ, YANG G-Y, SERIL DN, LIAO J, KIM S: Inhibition of 4-(methylnitrosamino)-1-(3-pyridy1)-1- butanone induced lung tumorigenesis by dietary olive oil and squalene. Carcinogenesis (1998) 19:703–706.
   PubMed Web of Science ®Google Scholar
• SMITH TJ, KIM S, LEE M-J, YANG G-Y, NEWMARK HL, YANG CS: Inhibition of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK)-induced lung tumorige-nesis and DNA oxidation by dietary squalene. Proc. Am. Assoc. Cancer Res. (1999) 40:262.
   Google Scholar
• MURAKOSHI M, NISHINO H, TOKUDA H et al.: Inhibitionby squalene of the tumor-promoting activity of 12-0-tetradecanoylphorbol-13-acetate in mouse skin carcinogenesis. Int. J. Cancer (1992) 52:950–952.
   PubMed Web of Science ®Google Scholar
• YAMAGUCHI T, NAKAGAWA M, HIDAKA K et al: Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl) methyl]-1 - (2-chloroethyl)-nitrosourea in a murine tumor system. Jpn. J. Cancer Res. (Gann) (1985) 76:1021–1026.
   PubMedGoogle Scholar
• DESAI KN, WEI H, LAMARTINIERE CA: The preventiveand therapeutic potential of the squalene-containing compound, Roidex, on tumor promotion and regres-sion. Cancer Lett. (1996) 101:93–96.
   PubMed Web of Science ®Google Scholar
• HECHT SS: Recent studies on mechanisms of bioactiva-tion and detoxification of 4-(methylnitro-samino)-1-(3-pyridy1)-1-butanone (NNK), a tobacco-specific lung carcinogen. Crit. Rev. Toxkol. (1996) 26:163–181.
   PubMed Web of Science ®Google Scholar
• •Detailed review of the metabolic activation of NNK in animals and humans and cytochrome P450 enzymes involved.
   Google Scholar
• KATDARE M, SINGHAL H, NEWMARK H, OSBORNE MP, TELANG NT: Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibi-tors. Cancer Lett. (1997) 111:141–147.
   PubMed Web of Science ®Google Scholar
• NEWMARK HL: Squalene, olive oil and cancer risk. Review and hypothesis. Ann. NY Acad. Sci. (1999) 889:193–203.
   PubMed Web of Science ®Google Scholar
• NEWMARK HL: Squalene, olive oil and cancer risk: a review and hypothesis. Cancer Epidemiol. Biomarkers Prey. (1997) 6:1101–1103.
   PubMed Web of Science ®Google Scholar
• •First paper to hypothesise inhibition of Ras farnesylation as a mechanism for the inhibition of carcinogenesis by squalene.
   Google Scholar
• STRANDBERG TE, TILVIS RS, MIETTINEN TA: Variations of hepatic cholesterol precursors during altered flows of endogenous and exogenous squalene in the rat. Biochim. Biophys. Acta (1989) 1001:150–156.
   PubMed Web of Science ®Google Scholar
• EL-SOHEMY A, BRUCE WR, ARCHER MC: Inhibition of rat mammary tumorigenesis by dietary cholesterol. Carcinogenesis (1996) 17:159–162.
   PubMed Web of Science ®Google Scholar
• GOLDSTEIN JL, BROWN MS: Regulation of the mevalo-nate pathway. Nature (1990) 343:425–430.
   PubMed Web of Science ®Google Scholar
• RAO KN: The significance of the cholesterol biosyn-thetic pathway in cell growth and carcinogenesis. [Review]. AntiCancer Res. (1995) 15:309–314.
   PubMed Web of Science ®Google Scholar
• COX AD, DER CJ: The ras/cholesterol connection:implications for ras oncogenicity. Crit. Rev. Oncog. (1992) 3:365–400.
   PubMedGoogle Scholar
• SMITH TJ, GUO Z, HONG J-Y, NING SM, THOMAS PE,YANG CS: Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK) in microsomes of rat lung and nasal mucosa. Carcinogenesis (1992) 13:1409–1414.
   PubMed Web of Science ®Google Scholar
• SMITH TJ, GUO Z, GONZALEZ FJ, GUENGERICH FP, STONER GD, YANG CS: Metabolism of 4-(methylnitro-samino)-1-(3-pyridy1)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res. (1992) 52:1757–1763.
   PubMed Web of Science ®Google Scholar
• GUO Z, SMITH TJ, THOMAS PE, YANG CS: Metabolism of4-(methylnitro samino)-1-(3-pyridy1)-1-butn one (NNK) by inducible and constitutive cytochrome P450 enzymes in rats. Arch. Biochem. Biophys. (1992) 298:279–286.
   PubMed Web of Science ®Google Scholar
• SMITH TJ, STONER GD, YANG CS: Activation of4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase and hydroperoxides. Cancer Res. (1995) 55:5566–5573.
   PubMed Web of Science ®Google Scholar
• SMITH TJ, GUO Z, LI C, NING SM, THOMAS PE, YANG CS:Mechanisms of inhibition of 4-(methylnitro-samino)-1-(3-pyridy1)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate. Cancer Res. (1993) 53:3276–3282.
   PubMed Web of Science ®Google Scholar
• PATTEN CP, SMITH TJ, MURPHY SE et al: Kinetic analysisof the activation of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes. Arch. Biochem. Biophys. (1996) 333:127–138.
   PubMed Web of Science ®Google Scholar
• KOHNO Y, EGAWA Y, ITOH S, NAGAOKA S, TAKAHASHIM, MUKAI K: Kinetic study of quenching reaction of singlet oxygen and scavenging reaction of free radical by squalene in fl-butanol. Biochim. Biophys. Acta (1995) 1256:52–56.
   PubMed Web of Science ®Google Scholar
• STORM HM, OH SY, KIMLER BF, NORTON S: Radioprotec-tion of mice by dietary squalene. Lipids (1993) 28:555–559.
   PubMed Web of Science ®Google Scholar
• GAJKOWSKA B, SMIALEK M, OSTROWSKI RP, PIOTROWSKI P, FRONTCZAK-BANIEWICZ M: The experimental squalene encepaloneuropathy in the rat. Exp. Toxicol. Pathol. (1999) 51:75–80.
   PubMedGoogle Scholar
• SMIALEK M, GAJKOWSKA B, OSTROWSKI RP, PIOTROWSKI P: Experimental squalene encephaloneu-ropathy in the rat. FoliaNeuropathol. (1997) 35:262–264.
   Google Scholar